Advertisement

Ciprofloxacin

Microbiology — Pharmacokinetics — Clinical Experience

  • Editors
  • H. C. Neu
  • D. S. Reeves
Book

Part of the Current Topics in Infectious Diseases and Clinical Microbiology book series (CTIDCM, volume 1)

Table of contents

  1. Front Matter
    Pages I-VII
    PDF

  2. Microbiology

    1. Front Matter
      Pages 1-1
      PDF

    2. Articles

      1. A Laboratory Assessment of Ciprofloxacin and Comparable Antimicrobial Agents
        L. Shrire, J. Saunders, R. Traynor, H. J. Kornhof
        Pages 3-7
      2. Comparative in Vitro Activity of Five Quinoline Derivatives and Five Other Antimicrobial Agents Used in Oral Therapy
        J. A. A. Hoogkamp-Korstanje
        Pages 8-13
      3. The In Vitro and In Vivo Activity of Ciprofloxacin
        H.-J. Zeiler, K. Grohe
        Pages 14-18
      4. The Activity of Ciprofloxacin and Other 4-Quinolones Against Chlamydia trachomatis and Mycoplasmas In Vitro
        G. L. Ridgway, G. Mumtaz, F. G. Gabriel, J. D. Oriel
        Pages 19-21
      5. Mutational Resistance to 4-Quinolone Antibacterial Agents
        J. T. Smith
        Pages 22-25
      6. Antibacterial Activity of Ciprofloxacin in Conventional Tests and in a Model of Bacterial Cystitis
        D. Greenwood, S. Baxter, A. Cowlishaw, A. Eley, G. J. Slater
        Pages 26-29

    3. Notes

      1. Comparison of the in Vitro Activity of Ciprofloxacin (Bay o 9867) and Norfloxacin Against Gastrointestinal Tract Pathogens
        M. Diez-Enciso, G. Mas-Jimenez, A. Velasco-Cerrudo, A. Gutierrez-Altes
        Pages 30-30
      2. In Vitro Activity of Ciprofloxacin, Azthreonam and Ceftazidime Against Serratia marcescens and Pseudomonas aeruginosa
        J. Righter
        Pages 31-32
      3. In Vitro Activity of Ciprofloxacin Against Bacteroides, Haemophilus influenzae and Branhamella catarrhalis
        B. Olsson-Liljequist
        Pages 33-34
      4. In Vitro Activity of Ciprofloxacin Against Brucella melitensis
        M. Gobernado, E. Cantón, M. Santos
        Pages 34-34
      5. In Vitro Activity of Ciprofloxacin Against Clinical Isolates of Chlamydia trachomatis
        H. Meier-Ewert, G. Weil, G. Millott
        Pages 35-35
      6. Susceptibility of Legionella spp. to Quinolone Derivatives and Related Organic Acids
        G. Ruckdeschel, W. Ehret, A. Ahl
        Pages 36-36
      7. In Vitro Activity of Ciprofloxacin and Norfloxacin Against Gardnerella vaginalis
        K. Machka
        Pages 37-37
      8. In Vitro Activity of Ciprofloxacin Against Group JK Corynebacteria
        K. Machka, H. Balg
        Pages 38-38

  3. Pharmacokinetics

    1. Front Matter
      Pages 39-39
      PDF

    2. Articles

      1. Pharmacokinetics of Ciprofloxacin in Healthy Volunteers after Oral and Intravenous Administration
        K. Borner, G. Höffken, H. Lode, P. Koeppe, C. Prinzing, P. Glatzel et al.
        Pages 41-48
      2. Pharmacokinetics of Ciprofloxacin after Intravenous and Increasing Oral Doses
        T. Bergan, S. B. Thorsteinsson, I. M. Kolstad, S. Johnsen
        Pages 49-54
      3. Single and Multiple Dose Pharmacokinetics of Ciprofloxacin
        U. Ullmann, W. Giebel, A. Dalhoff, P. Koeppe
        Pages 55-58
      4. Penetration of Ciprofloxacin into Bronchial Secretions
        E. Bergogne-Bérézin, G. Berthelot, P. Even, M. Stern, P. Reynaud
        Pages 59-62
      5. Effect of Oral Ciprofloxacin on the Faecal Flora of Healthy Volunteers
        H. A. Holt, D. A. Lewis, L. O. White, S. Y. Bastable, D. S. Reeves
        Pages 63-67
      6. Diffusion of Ciprofloxacin into Prostatic Fluid
        A. Dalhoff, W. Weidner
        Pages 68-70
      7. Dose- and Sex-Independent Disposition of Ciprofloxacin
        D. Höffler, A. Dalhoff, W. Gau, D. Beermann, A. Michl
        Pages 71-74

    3. Notes

      1. Penetration of Ciprofloxacin into Cerebrospinal Fluid
        G. Valainis, D. Thomas, G. Pankey
        Pages 75-76
      2. Penetration of Ciprofloxacin into Female Pelvic Tissues
        S. Segev, E. Rubinstein, J. Shick, O. Rabinovitch, M. Dolitsky
        Pages 76-78
      3. Intraperitoneal Penetration of Ciprofloxacin
        M. R. Lockley, R. Waldron, R. Wise, I. A. Donovan
        Pages 78-79
      4. Concentrations of Ciprofloxacin in Serum and Prostatic Tissue in Patients Undergoing Transurethral Resection
        M. Grabe, A. Forsgren, T. Björk
        Pages 80-81
      5. Penetration of Ciprofloxacin into Kidney, Fat, Muscle and Skin Tissue
        F. D. Daschner, M. Westenfelder, A. Dalhoff
        Pages 81-82

  4. Clinical Experience

    1. Front Matter
      Pages 83-83
      PDF

    2. Review

      1. Overview of Clinical Experience with Ciprofloxacin
        A. P. Ball
        Pages 85-90

    3. Articles

      1. Clinical Experience with Ciprofloxacin in the USA
        G. Arcieri, R. August, N. Becker, C. Doyle, E. Griffith, G. Gruenwaldt et al.
        Pages 91-96
      2. Ciprofloxacin in the Treatment of Acute Exacerbations of Chronic Bronchitis
        B. I. Davies, F. P. V. Maesen, C. Baur
        Pages 97-102
      3. Evaluation of Ciprofloxacin in the Treatment of Pseudomonas aeruginosa Infections
        H. Giamarellou, N. Galanakis, C. Dendrinos, J. Stefanou, E. Daphnis, G. K. Daikos
        Pages 103-106
      4. Use of Ciprofloxacin in the Treatment of Pseudomonas aeruginosa Infections
        F. Follath, M. Bindschedler, M. Wenk, R. Frei, H. Stalder, H. Reber
        Pages 107-111
      5. Ciprofloxacin in the Treatment of Acute Bacterial Diarrhea: A Double Blind Study
        H. Pichler, G. Diridl, D. Wolf
        Pages 112-114
      6. Treatment of Uncomplicated Gonococcal Urethritis in Men with Two Dosages of Ciprofloxacin
        M. J. A. M. Tegelberg-Stassen, J. C. S. van der Hoek, L. Mooi, J. H. T. Wagenvoort, T. van Joost, M. F. Michel et al.
        Pages 115-117

    4. Notes

      1. Ciprofloxacin in the Treatment of Urinary Tract Infection due to Enterobacteria
        J. Guibert, D. Destrée, C. Konopka, J. Acar
        Pages 118-119
      2. Ciprofloxacin in the Treatment of Infections Caused by Gentamicin-Resistant Gram-Negative Bacteria
        S. Mehtar, Y. Drabu, P. Blakemore
        Pages 119-122
      3. Ciprofloxacin in the Treatment of Urinary Tract Infection in Patients with Multiple Sclerosis
        H. Van Poppel, M. Wegge, H. Dammekens, V. Chysky
        Pages 122-124
      4. Comparison of Intravenous Ciprofloxacin and Mezlocillin in Treatment of Complicated Urinary Tract Infection
        H. J. Peters
        Pages 124-126
      5. Ciprofloxacin in the Treatment of Urinary Tract Infections Caused by Pseudomonas aeruginosa and Multiresistant Bacteria
        S. Saavedra, C. H. Ramírez-Ronda, M. Nevárez
        Pages 126-128
      6. Clinical Evaluation of Treatment with Ciprofloxacin
        R. Finch, M. Whitby, C. Craddock, A. Holliday, J. Martin, R. Pilkington
        Pages 128-130
      7. Treatment of Chronic Salmonella Carriers with Ciprofloxacin
        G. Diridl, H. Pichler, D. Wolf
        Pages 131-132

About this book

Keywords

Antibiotika Antibiotikum Bakterien Chemotherapie Ciprofloxacin Droge Infektion Infektionen Mikrobiologie Pharmakokinetik Pseudomonas Resistenz Therapeut Wachstum antimicrobial

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-663-01930-5
  • Copyright Information Springer Fachmedien Wiesbaden 1986
  • Publisher Name Vieweg+Teubner Verlag, Wiesbaden
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-663-01931-2
  • Online ISBN 978-3-663-01930-5
  • Buy this book on publisher's site
Industry Sectors
Pharma
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods